In vitro drug-drug interactions with perospirone and concomitantly administered drugs in human liver microsomes.
In vitro metabolism studies were conducted to assess drug-drug interactions between perospirone, an antipsychotic agent, and concomitantly administered drugs--biperiden, flunitrazepam, haloperidol, and diazepam--using human liver microsomes. The metabolism of perospirone in the presence of 100 microg/ml drugs was decreased to 45-73% of that in their absence, whereas no effects were observed with any of the drugs at 1 microg/ml or lower. The effects of perospirone on the metabolism of concomitantly administered drugs were also assessed, and no inhibitory effect was observed. Thus, the metabolism of perospirone and concomitantly administered drugs did not demonstrate any marked mutual inhibition in the human liver microsomes. On the other hand, the perospirone metabolism was markedly reduced by ketoconazole indicating a major role for CYP 3A4. Based on the inhibition constant (Ki) for perospirone metabolism and the plasma unbound concentration of ketoconazole, in vivo perospirone clearance was estimated to be reduced to 64-90% of the control level. Thus careful attention should be paid to the possibility of increase in unchanged perospirone concentration when perospirone is co-administered with drugs that are known as CYP3A4 inhibitors, including macrolide antibiotics and other imidazole antifungals.
D000935:Antifungal Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000378:metabolism* / Q000493:pharmacokinetics; D001712:Biperiden / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000378:metabolism* / Q000493:pharmacokinetics; D054833:Isoindoles; D007654:Ketoconazole / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D018727:Muscarinic Antagonists / Q000737:chemistry; D013844:Thiazoles / Q000378:metabolism* / Q000493:pharmacokinetics
D000935:Antifungal Agents; D014150:Antipsychotic Agents; D007211:Indoles; D054833:Isoindoles; D018727:Muscarinic Antagonists; D013844:Thiazoles; D001712:Biperiden; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; C065533:perospirone; D007654:Ketoconazole